Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-05-2019 | Glioma | Letter to the Editor

The mean striatal ¹⁸F-DOPA uptake is not a reliable cut-off threshold for biological tumour volume definition of glioma

Authors: Francesco Cicone, Luciano Carideo, Giuseppe Minniti, Francesco Scopinaro

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2019

Excerpt

Dear Editor, …

Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, et al. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-018-4207-9.

Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, et al. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016;18:1199–208.CrossRefPubMedPubMedCentral

Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Grogan T, et al. Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy. Clin Cancer Res. 2014;20:3550–9.CrossRefPubMedPubMedCentral

Cicone F, Carideo L, Scaringi C, Arcella A, Giangaspero F, Scopinaro F, et al. 18F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma. Ann Nucl Med. 2019. https://doi.org/10.1007/s12149-018-01328-3.

Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, et al. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med. 2006;47:904–11.PubMed

Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, et al. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study. Neuro Oncol. 2013;15:1058–67.CrossRefPubMedPubMedCentral

Youland RS, Pafundi DH, Brinkmann DH, Lowe VJ, Morris JM, Kemp BJ, et al. Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas. J Neurooncol. 2018;137:583–91.CrossRefPubMedPubMedCentral

Karunanithi S, Sharma P, Kumar A, Khangembam BC, Bandopadhyaya GP, Kumar R, et al. 18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2013;40:1025–35.CrossRefPubMed

Herrmann K, Czernin J, Cloughesy T, Lai A, Pomykala KL, Benz MR, et al. Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients. Neuro Oncol. 2014;16:603–9.CrossRefPubMed

10.

Cicone F, Filss CP, Minniti G, Rossi-Espagnet C, Papa A, Scaringi C, et al. Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI. Eur J Nucl Med Mol Imaging. 2015;42:905–15.CrossRefPubMed

11.

Rossi Espagnet MC, Romano A, Mancuso V, Cicone F, Napolitano A, Scaringi C, et al. Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET. Br J Radiol. 2016;89:20160476.CrossRefPubMedPubMedCentral

12.

Verger A, Metellus P, Sala Q, Colin C, Bialecki E, Taieb D, et al. IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas. Eur J Nucl Med Mol Imaging. 2017;44:1306–11.CrossRefPubMed

13.

Morana G, Piccardo A, Tortora D, Puntoni M, Severino M, Nozza P, et al. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET. Eur J Nucl Med Mol Imaging. 2017;44:2084–93.CrossRefPubMed

14.

Carideo L, Minniti G, Mamede M, Scaringi C, Russo I, Scopinaro F, et al. 18F-DOPA uptake parameters in glioma: effects of patients’ characteristics and prior treatment history. Br J Radiol. 2018;91:20170847.CrossRefPubMedPubMedCentral

15.

Stegmayr C, Stoffels G, Kops ER, Lohmann P, Galldiks N, Shah NJ, et al. Influence of dexamethasone on O-(2-[18F]-fluoroethyl)-L-tyrosine uptake in the human brain and quantification of tumor uptake. Mol Imaging Biol. 2018. https://doi.org/10.1007/s11307-018-1221-z.

Title: The mean striatal 18F-DOPA uptake is not a reliable cut-off threshold for biological tumour volume definition of glioma
Authors: Francesco Cicone
Luciano Carideo
Giuseppe Minniti
Francesco Scopinaro
Publication date: 01-05-2019
Publisher: Springer Berlin Heidelberg
Keywords: Glioma
Glioma
Glioma
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2019
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-019-4276-4

At a glance: The STEP trials

Springer Medicine

The mean striatal ¹⁸F-DOPA uptake is not a reliable cut-off threshold for biological tumour volume definition of glioma

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2019

Imaging of tau deposits in adults with Niemann-Pick type C disease: a case-control study

Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and safety according to prior use of chemotherapy in routine clinical practice

68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

Deauville score: the Phoenix rising from ashes

Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study

Bronchial inflammatory granulation after endobronchial ultrasound-guided transbronchial needle aspiration and immunotherapy